Cargando…
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
BACKGROUND: Accumulating evidence suggests a tumor suppressive role for miR-34a in human carcinogenesis. However, its precise biological role remains largely elusive. This study aimed to reveal the association of the miR-34a expression and its modulation of sensitivity to cisplatin in muscle-invasiv...
Autores principales: | Li, Heng, Yu, Gan, Shi, Runlin, Lang, Bin, Chen, Xianguo, Xia, Ding, Xiao, Haibing, Guo, Xiaolin, Guan, Wei, Ye, Zhangqun, Xiao, Wei, Xu, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022035/ https://www.ncbi.nlm.nih.gov/pubmed/24423412 http://dx.doi.org/10.1186/1476-4598-13-8 |
Ejemplares similares
-
Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014) -
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022) -
Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence
por: Xiao, Wei, et al.
Publicado: (2014) -
A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer
por: Zhou, Hui, et al.
Publicado: (2015) -
miR‐490‐5p suppresses tumour growth in renal cell carcinoma through targeting PIK3CA
por: Chen, Ke, et al.
Publicado: (2015)